234 related articles for article (PubMed ID: 19542399)
1. Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial.
Moriyasu F; Itoh K
AJR Am J Roentgenol; 2009 Jul; 193(1):86-95. PubMed ID: 19542399
[TBL] [Abstract][Full Text] [Related]
2. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of sonazoid (perflubutane) for contrast-enhanced ultrasound in the differentiation of focal breast lesions: phase 3 multicenter clinical trial.
Miyamoto Y; Ito T; Takada E; Omoto K; Hirai T; Moriyasu F
AJR Am J Roentgenol; 2014 Apr; 202(4):W400-7. PubMed ID: 24660739
[TBL] [Abstract][Full Text] [Related]
5. Liver specific phase of perflubutane microbubbles contrast-enhanced ultrasound for potential use in the diagnosis of focal liver lesions.
Ji Q; Liu G; Sun X; Liu G; Lu M; Xie X; Xu M; Zhang Y; Zheng S
J Xray Sci Technol; 2013; 21(3):409-18. PubMed ID: 24004871
[TBL] [Abstract][Full Text] [Related]
6. Focal liver tumors: characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT.
Luo W; Numata K; Morimoto M; Kondo M; Takebayashi S; Okada M; Morita S; Tanaka K
Radiology; 2009 Apr; 251(1):287-95. PubMed ID: 19221060
[TBL] [Abstract][Full Text] [Related]
7. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
8. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma.
Shagdarsuren B; Tamai H; Shingaki N; Mori Y; Maeshima S; Nuta J; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
J Ultrasound Med; 2016 Jul; 35(7):1383-91. PubMed ID: 27208196
[TBL] [Abstract][Full Text] [Related]
10. Characterization of malignant focal liver lesions with contrast-enhanced 40 MHz ultrasound imaging in hepatitis B virus X transgenic mice: a feasibility study.
Liao AH; Cheng YC; Weng CH; Tsai TF; Lin WH; Yeh SH; Yeh WC; Li PC
Ultrason Imaging; 2008 Oct; 30(4):203-16. PubMed ID: 19507674
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions.
Pirovano G; Vanzulli A; Marti-Bonmati L; Grazioli L; Manfredi R; Greco A; Holzknecht N; Daldrup-Link HE; Rummeny E; Hamm B; Arneson V; Imperatori L; Kirchin MA; Spinazzi A
AJR Am J Roentgenol; 2000 Oct; 175(4):1111-20. PubMed ID: 11000175
[TBL] [Abstract][Full Text] [Related]
12. Real-time contrast-enhanced sonographically guided biopsy or radiofrequency ablation of focal liver lesions using perflurobutane microbubbles (sonazoid): value of Kupffer-phase imaging.
Park HS; Kim YJ; Yu MH; Jung SI; Jeon HJ
J Ultrasound Med; 2015 Mar; 34(3):411-21. PubMed ID: 25715362
[TBL] [Abstract][Full Text] [Related]
13. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced ultrasonography for characterization of focal splenic lesions in dogs.
Nakamura K; Sasaki N; Murakami M; Bandula Kumara WR; Ohta H; Yamasaki M; Takagi S; Osaki T; Takiguchi M
J Vet Intern Med; 2010; 24(6):1290-7. PubMed ID: 21039867
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
[TBL] [Abstract][Full Text] [Related]
16. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography.
Leen E; Ceccotti P; Kalogeropoulou C; Angerson WJ; Moug SJ; Horgan PG
AJR Am J Roentgenol; 2006 Jun; 186(6):1551-9. PubMed ID: 16714643
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich C; von Herbay A; Friedrich-Rust M; Kunze G; Becker D; Will U; Kratzer W; Albert FW; Pachmann C; Dirks K; Strunk H; Greis C; Bernatik T
Ultraschall Med; 2008 Oct; 29(5):499-505. PubMed ID: 19241506
[TBL] [Abstract][Full Text] [Related]
18. Characterization of focal liver lesions with a new ultrasound contrast agent using continuous low acoustic power imaging: comparison with contrast enhanced spiral CT.
Passamonti M; Vercelli A; Azzaretti A; Rodolico G; Calliada F
Radiol Med; 2005 Apr; 109(4):358-69. PubMed ID: 15883520
[TBL] [Abstract][Full Text] [Related]
19. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
[TBL] [Abstract][Full Text] [Related]
20. Value of contrast-enhanced ultrasound using perflubutane microbubbles for diagnosing liver fibrosis and cirrhosis in rats.
Liu GJ; Ji Q; Moriyasu F; Xie XY; Wang W; Wong LH; Lin MX; Lu MD
Ultrasound Med Biol; 2013 Nov; 39(11):2158-65. PubMed ID: 23969165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
